Friday, May 10, 2002
13:00 14:45 (Auditorium 1)
From Research to Clinical Evidence:
Defining the Standard for Postmenopausal Women
Chair: P.D. Delmas
Osteoporosis: Who should be treated?
Are progestins bone-active agents?
Discovery of Lasofoxifene: the next generation of SERMs and the Lasofoxifene pre-clinical evaluation
Emerging data and experience with Lasofoxifene: highlights from clinical trials
A. Moffett, Jr.
Extraskeletal effects of HRT and SERMs in postmenopausal women: Breast cancer, cardiovascular disease and cognition